International Congress on ATTR Amyloidosis

LIVE: October 21, 2023

The 2nd International Congress on ATTR Amyloidosis (ICAA) will explore the disease state, diagnosis, and the latest advancements and treatments in the management of amyloidosis. This conference is an opportunity to gain knowledge on new developments in this complex disease. Leading experts will present clinically relevant information that you will find immediately useful in the care of your patients.

Virtual Event
swoosh
swoosh

LETTER FROM THE CO-CHAIRS

Dear Medical and Scientific Colleagues:

It is our pleasure and privilege to welcome you to the 2nd Biennial International Congress on ATTR Amyloidosis (ICAA) Conference. From the moment you enter the Virtual Conference Center, you’ll spend two days engaging in a lively, interactive conference experience. We will begin with a foundational overview of ATTR-CM, reviewing best practices in diagnosis and treatment of the disease. Then we will move on to provide guidance on tracking disease progression, followed by a robust roundtable discussion on the latest clinical trial results in ATTR-CM.

In the afternoon, we will look at some cases and have a lively discussion. Finally, we will turn our attention to the future of ATTR-CM Management, exploring stabilizer and silencer combination therapy as well as other emerging therapies coming down the pipeline. You will have ample opportunities throughout the day to ask questions and get answers from our esteemed presenters.

As in any live conference venue, you will also find robust opportunities to interact with your colleagues beyond the educational sessions.

Once again, welcome! We hope you will enjoy this one-of-a-kind virtual conference, benefit from the learning opportunities, and gather many clinical pearls to “bring home” to your practice!

CO-CHAIRS


 


 

company name

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.  

company name

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.